推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733,021-33632861

chinasupport@letpub.com

登录 注册 新注册优惠

Molecular Cancer

2023年6月最新SCI影响因子数据已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎点击此处反馈给我们。

按期刊名首写字母查看 MOL CANCER最新评论:从创刊以来重庆医科大一共发过10篇,并没有出现过一个科室中多篇的情况 (2023-10-15)


期刊名:   ISSN:   研究方向:   影响因子: -   SCI收录:
大类学科:   小类学科:   中科院分区:   是否OA期刊:   结果排序:

按研究方向查看:


Molecular Cancer期刊基本信息Hello,您是该期刊的第164629位访客

基本信息 登录收藏
期刊名字Molecular CancerMolecular Cancer

MOL CANCER
(此期刊被最新的JCR期刊SCIE收录)

LetPub评分
8.5
61人评分
我要评分

声誉
8.6

影响力
8.3

速度
8.7

期刊ISSN1476-4598
微信扫码收藏此期刊
2022-2023最新影响因子
(数据来源于搜索引擎)
37.3 点击查看影响因子趋势图
实时影响因子 截止2023年9月27日:16.294
2022-2023自引率2.70%点击查看自引率趋势图
五年影响因子33.1
h-index 103
CiteScore
CiteScoreSJRSNIPCiteScore排名
64.908.7035.740
学科分区排名百分位
大类:Biochemistry, Genetics and Molecular Biology
小类:Cancer Research
Q12 / 214
大类:Biochemistry, Genetics and Molecular Biology
小类:Molecular Medicine
Q12 / 171
大类:Biochemistry, Genetics and Molecular Biology
小类:Oncology
Q14 / 366

期刊简介Molecular Cancer promotes the exchange of ideas, concepts and findings in any area of cancer and related biomedical science, from a molecular point of view. Molecular Cancer is interested in articles from basic, translational and clinical research, opening new avenues for the understanding, prevention, diagnosis and treatment of cancer. Topics of interest include, but are not limited to: cell and tumor biology, angiogenesis, animal models, metastasis, cancer antigens and the immune response to them, cellular signalling and molecular biology, epidemiology, genetic and molecular profiling of cancer and molecular targets, cancer stem cells, DNA damage and repair, cell cycle, apoptosis, molecular virology and vaccine- and antibody-based cancer therapies.
期刊官方网站http://molecular-cancer.biomedcentral.com
期刊投稿网址https://submission.nature.com/new-submission/12943/3
作者指南网址http://molecular-cancer.biomedcentral.com/submission-guidelines
期刊语言要求经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足Molecular Cancer的语言要求,还能让Molecular Cancer编辑和审稿人得到更好的审稿体验,让稿件最大限度地被Molecular Cancer编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢
提交文稿
是否OA开放访问Yes
OA期刊相关信息
文章处理费:需要( GBP3170; )
文章处理费豁免:查看说明

其他费用:没有
期刊主题关键词:oncology、tumour biology、cancer antigens
相关链接:Aims & ScopeAuthor InstructionsEditorial BoardBlind peer review
通讯方式BIOMED CENTRAL LTD, 236 GRAYS INN RD, FLOOR 6, LONDON, ENGLAND, WC1X 8HL
出版商BioMed Central
涉及的研究方向医学-生化与分子生物学
出版国家或地区ENGLAND
出版语言English
出版周期Monthly
出版年份2002
年文章数 167点击查看年文章数趋势图
Gold OA文章占比100.00%
研究类文章占比:
文章 ÷(文章 + 综述)
65.27%
WOS期刊SCI分区
2022-2023年最新版
WOS分区等级:1区

按学科分区JIF分区JIF排名JIF百分位
学科:BIOCHEMISTRY & MOLECULAR BIOLOGY
类别:SCIE
Q14/285
学科:ONCOLOGY
类别:SCIE
Q18/241
中科院《国际期刊预警
名单(试行)》名单
2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2021年01月发布的2020版:不在预警名单中
中科院SCI期刊分区
2022年12月最新升级版
点击查看中科院SCI期刊分区趋势图
大类学科小类学科Top期刊综述期刊
医学 4区1区4区
BIOCHEMISTRY & MOLECULAR BIOLOGY
生化与分子生物学
2区1区1区
ONCOLOGY
肿瘤学
2区4区1区
中科院SCI期刊分区
2021年12月基础版
大类学科小类学科Top期刊综述期刊
医学 1区1区2区
BIOCHEMISTRY & MOLECULAR BIOLOGY
生化与分子生物学
3区4区1区
ONCOLOGY
肿瘤学
2区1区1区
中科院SCI期刊分区
2021年12月升级版
大类学科小类学科Top期刊综述期刊
医学 4区1区2区
BIOCHEMISTRY & MOLECULAR BIOLOGY
生化与分子生物学
2区1区1区
ONCOLOGY
肿瘤学
3区3区1区
中科院SCI期刊分区
2020年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学 2区1区4区
BIOCHEMISTRY & MOLECULAR BIOLOGY
生化与分子生物学
2区4区1区
ONCOLOGY
肿瘤学
4区3区1区
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE)
Scopus (CiteScore)
Directory of Open Access Journals (DOAJ)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1476-4598%5BISSN%5D
平均审稿速度网友分享经验:
平均2月
平均录用比例网友分享经验:
约50%
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)后论文在Molecular Cancer顺利发表。
快看看作者怎么说吧:服务好评 论文致谢
期刊常用信息链接
同领域相关期刊 Molecular Cancer期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 Molecular Cancer中科院SCI期刊分区趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
Molecular Cancer上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 中科院SCI期刊分区趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发表论文
  • 中科院SCI期刊分区相关期刊
  • 同类著名期刊名称 h-index CiteScore
    NATURE MEDICINE497107.50
    CELL705102.00
    Molecular Plant8529.50
    NATURE STRUCTURAL & MOLECULAR BIOLOGY025.30
    Annual Review of Biochemistry26842.00
    Molecular Cell35629.20
    TRENDS IN MICROBIOLOGY17227.40
    NUCLEIC ACIDS RESEARCH45232.30
    Nature Chemical Biology18223.40
    TRENDS IN BIOCHEMICAL SCIENCES25323.00
    中科院SCI期刊分区同大类学科的热搜期刊 浏览次数
    MEDICINE570996
    BIOMEDICINE & PHARMACOTHERAPY423001
    Frontiers in Pharmacology420141
    Frontiers in Immunology384566
    JOURNAL OF ETHNOPHARMACOLOGY376128
    Frontiers in Oncology358729
    Theranostics304885
    International Journal of Nanomedicine289915
    CANCER LETTERS289274
    Molecular Medicine Reports286061
  •  

    Molecular Cancer Molecular Cancer
    我来预测明年:
    稳步上升 表现平稳 逐渐下降  刷新
  •  

     
  •  

     
  •  

     
  • 中国学者近期发表的论文
    1.Advances in immunology and immunotherapy for mesenchymal gastrointestinal cancers

    Author: Li, Bo; Chen, Hui; Yang, Shaohua; Chen, Feng; Xu, Liangliang; Li, Yan; Li, Mingzhe; Zhu, Chengming; Shao, Fangyuan; Zhang, Xinhua; Deng, Chuxia; Zeng, Leli; He, Yulong; Zhang, Changhua
    Journal: MOLECULAR CANCER. 2023; Vol. 22, Issue 1, pp. -. DOI: 10.1186/s12943-023-01770-6
        PubMed      DOI
    2.A novel protein encoded by circINSIG1 reprograms cholesterol metabolism by promoting the ubiquitin-dependent degradation of INSIG1 in colorectal cancer

    Author: Xiong, Li; Liu, Hua-shan; Zhou, Chi; Yang, Xin; Huang, Liang; Jie, Hai-qing; Zeng, Zi-wei; Zheng, Xiao-bin; Li, Wen-xin; Liu, Zhan-zhen; Kang, Liang; Liang, Zhen-xing
    Journal: MOLECULAR CANCER. 2023; Vol. 22, Issue 1, pp. -. DOI: 10.1186/s12943-023-01773-3
        PubMed      DOI
    3.Tumor-secreted exosomal miR-141 activates tumor-stroma interactions and controls premetastatic niche formation in ovarian cancer metastasis

    Author: Mo, Yulan; Leung, Leanne L.; Mak, Celia S. L.; Wang, Xueyu; Chan, Wai-Sun; Hui, Lynn M. N.; Tang, Hermit W. M.; Siu, Michelle K. Y.; Sharma, Rakesh; Xu, Dakang; Tsui, Stephen K. W.; Ngan, Hextan Y. S.; Yung, Mingo M. H.; Chan, Karen K. L.; Chan, David W. W.
    Journal: MOLECULAR CANCER. 2023; Vol. 22, Issue 1, pp. -. DOI: 10.1186/s12943-022-01703-9
        PubMed      DOI
    4.Safety and antitumor activity of GD2-Specific 4SCAR-T cells in patients with glioblastoma

    Author: Liu, Zhuohao; Zhou, Jiayi; Yang, Xinzhi; Liu, Yuchen; Zou, Chang; Lv, Wen; Chen, Cheng; Cheng, Kenneth King-yip; Chen, Tao; Chang, Lung-Ji; Wu, Dinglan; Mao, Jie
    Journal: MOLECULAR CANCER. 2023; Vol. 22, Issue 1, pp. -. DOI: 10.1186/s12943-022-01711-9
        PubMed      DOI
    5.CMTM6 overexpression confers trastuzumab resistance in HER2-positive breast cancer

    Author: Xing, Fei; Gao, Hongli; Chen, Guanglei; Sun, Lisha; Sun, Jiayi; Qiao, Xinbo; Xue, Jinqi; Liu, Caigang
    Journal: MOLECULAR CANCER. 2023; Vol. 22, Issue 1, pp. -. DOI: 10.1186/s12943-023-01716-y
        PubMed      DOI
    6.Crosstalk between 5-methylcytosine and N-6-methyladenosine machinery defines disease progression, therapeutic response and pharmacogenomic landscape in hepatocellular carcinoma

    Author: Tian, Yu; Xiao, Haijuan; Yang, Yanhui; Zhang, Pingping; Yuan, Jiahui; Zhang, Wei; Chen, Lijie; Fan, Yibao; Zhang, Jinze; Cheng, Huan; Deng, Tingwei; Yang, Lin; Wang, Weiwei; Chen, Guoyong; Wang, Peiqin; Gong, Peng; Niu, Xing; Zhang, Xianbin
    Journal: MOLECULAR CANCER. 2023; Vol. 22, Issue 1, pp. -. DOI: 10.1186/s12943-022-01706-6
        PubMed      DOI
    7.Advancements in nanoparticle-based treatment approaches for skin cancer therapy

    Author: Zeng, Leli; Gowda, B. H. Jaswanth; Ahmed, Mohammed Gulzar; Abourehab, Mohammed A. S.; Chen, Zhe-Sheng; Zhang, Changhua; Li, Jia; Kesharwani, Prashant
    Journal: MOLECULAR CANCER. 2023; Vol. 22, Issue 1, pp. -. DOI: 10.1186/s12943-022-01708-4
        PubMed      DOI
    8.Unravelling the enigma of siRNA and aptamer mediated therapies against pancreatic cancer

    Author: Liu, Zhe; Parveen, Neha; Rehman, Urushi; Aziz, Aisha; Sheikh, Afsana; Abourehab, Mohammed A. S.; Guo, Wei; Huang, Junhao; Wang, Zhenning; Kesharwani, Prashant
    Journal: MOLECULAR CANCER. 2023; Vol. 22, Issue 1, pp. -. DOI: 10.1186/s12943-022-01696-5
        PubMed      DOI
    9.CircZBTB44 promotes renal carcinoma progression by stabilizing HK3 mRNA structure

    Author: Li, Tushuai; Gu, Yue; Xu, Baocai; Kuca, Kamil; Zhang, Jie; Wu, Wenda
    Journal: MOLECULAR CANCER. 2023; Vol. 22, Issue 1, pp. -. DOI: 10.1186/s12943-023-01771-5
        PubMed      DOI
    10.A novel polypeptide encoded by the circular RNA ZKSCAN1 suppresses HCC via degradation of mTOR

    Author: Song, Runjie; Ma, Shuoqian; Xu, Jiajia; Ren, Xin; Guo, Peilan; Liu, Huijiao; Li, Peng; Yin, Fan; Liu, Mei; Wang, Qiang; Yu, Lei; Liu, Jiali; Duan, Binwei; Rahman, Nafis A.; Wolczynski, Slawomir; Li, Guangming; Li, Xiangdong
    Journal: MOLECULAR CANCER. 2023; Vol. 22, Issue 1, pp. -. DOI: 10.1186/s12943-023-01719-9
        PubMed      DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144642.90
    LANCET700133.20
    NEW ENGLAND JOURNAL OF MEDICINE933134.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION62245.40
    NATURE REVIEWS DRUG DISCOVERY289123.80
    BMJ-British Medical Journal015.30
    BMJ-British Medical Journal015.30
    NATURE REVIEWS IMMUNOLOGY35183.00
    NATURE MEDICINE497107.50
    Nature Reviews Disease Primers4860.90
    同分区等级的其他期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144642.90
    LANCET700133.20
    NEW ENGLAND JOURNAL OF MEDICINE933134.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION62245.40
    NATURE REVIEWS DRUG DISCOVERY289123.80
    NATURE REVIEWS MOLECULAR CELL BIOLOGY386164.40
    BMJ-British Medical Journal015.30
    BMJ-British Medical Journal015.30
    NATURE REVIEWS IMMUNOLOGY35183.00
    NATURE REVIEWS MICROBIOLOGY25060.20


以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分:

    同领域作者分享投稿经验:共5条 (包含回复)

我来分享

    关闭窗口

    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2023 中国: LetPub上海分公司    网站备案号:沪ICP备10217908号-1    沪公网安备号:31010402006960

    增值电信业务经营许可证:沪B2-20211595

    礼翰商务信息咨询(上海)有限公司      办公地址:上海市徐汇区漕溪北路88号圣爱大厦2103室

    United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451